Intervention

methylprednisolone

ClinicalTrials.gov intervention label

Clinical trials23
Recruiting0
Common conditions25
Lead sponsors shown15

Clinical trials

23 shown
Management Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADANCT02205489 · 2014-10-01
COMPLETED
Alternative Treatment Paradigm for Natalizumab TrialNCT01710228 · 2013-07-01
WITHDRAWN
A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid ArthritisNCT01382940 · 2011-07-26
COMPLETED
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)NCT01086540 · 2011-06-24
COMPLETED
Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung CancerNCT01789892 · 2011-06-01
WITHDRAWN
Cyclic Oral Methylprednisolone Trial in Multiple SclerosisNCT01305837 · 2011-04-01
COMPLETED
A Study of Glucocorticoid Use to Evaluate Systematic Methylprednisolone Reduction in Patients With Rheumatoid Arthritis on Background RoActemra/Actemra (Tocilizumab) (ACT-ALONE)NCT01219933 · 2011-01-01
COMPLETED
Treatment Interruption of NatalizumabNCT01071083 · 2010-03-01
COMPLETED
Chronotherapy in Acute Multiple Sclerosis (MS) AttackNCT00764413 · 2009-04-01
TERMINATED
Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During RelapseNCT00753792 · 2008-11-01
COMPLETED
A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateNCT01000610 · 2008-03-17
COMPLETED
A Study of MabThera/Rituxan (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis and Inadequate Response to DMARD TherapyNCT02006706 · 2006-08-10
COMPLETED
Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantNCT00410657 · 2006-07-01
COMPLETED
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell TransplantNCT00309907 · 2006-04-01
COMPLETED
A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid ArthritisNCT00299104 · 2006-01-01
COMPLETED
A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving MethotrexateNCT00243412 · 2005-08-01
COMPLETED
Campath-1H + FK506 and Methylprednisolone for GVHDNCT00109993 · 2005-01-01
COMPLETED
Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon BetaNCT00493116 · 2003-10-01
COMPLETED
Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing AntibodiesNCT00492466 · 2003-03-01
COMPLETED
Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.NCT00037115 · 2002-05-01
WITHDRAWN
Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple SclerosisNCT00017628 · 2001-04-01
COMPLETED
Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune DiseasesNCT00006055 · 2000-03-01
UNKNOWN
Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate CancerNCT00003682 · 1998-10-01
TERMINATED

Common conditions

Rheumatoid Arthritis7Multiple Sclerosis4Graft Versus Host Disease3Relapsing-Remitting Multiple Sclerosis3Breast Cancer2Chronic Myeloproliferative Disorders2Gestational Trophoblastic Tumor2Leukemia2Lymphoma2Multiple Myeloma and Plasma Cell Neoplasm2Myelodysplastic Syndromes2Myelodysplastic/Myeloproliferative Diseases2Neuroblastoma2Ovarian Cancer2Testicular Germ Cell Tumor2Accelerated Phase Chronic Myelogenous Leukemia1Anemia, Hemolytic, Autoimmune1Autoimmune Thrombocytopenic Purpura1Blastic Phase Chronic Myelogenous Leukemia1Childhood Acute Lymphoblastic Leukemia in Remission1Childhood Acute Myeloid Leukemia in Remission1Childhood Chronic Myelogenous Leukemia1Childhood Myelodysplastic Syndromes1Chronic Phase Chronic Myelogenous Leukemia1Churg-Strauss Syndrome1

Leading sponsors

Hoffmann-La Roche4Biogen3Genentech, Inc.2Case Comprehensive Cancer Center1Children's Oncology Group1Copenhagen University Hospital, Rigshospitalet1Fairview University Medical Center1Fred Hutchinson Cancer Center1Genzyme, a Sanofi Company1Germans Trias i Pujol Hospital1MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute1National Institute of Allergy and Infectious Diseases (NIAID)1Northwestern Memorial Hospital1Ohio State University Comprehensive Cancer Center1Sykehuset Innlandet HF1

Trial status mix

COMPLETED17
WITHDRAWN3
TERMINATED2
UNKNOWN1

Phase mix

PHASE28
PHASE48
NA3
PHASE33
PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.